<?xml version="1.0" encoding="UTF-8"?>
<glossary id="dl1">
 <def-list>
  <title>Vocabulary</title>
  <def-item>
   <term>
    <bold>Coronavirus disease 2019 (COVID-19)</bold>
   </term>
   <def>
    <p>a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has been declared as a pandemic by WHO since March 11, 2020</p>
   </def>
  </def-item>
  <def-item>
   <term>
    <bold>antiviral vaccine</bold>
   </term>
   <def>
    <p>a biological preventive preparation strategy to train the immune systems to fight against viral pathogens</p>
   </def>
  </def-item>
  <def-item>
   <term>
    <bold>vaccine formulations</bold>
   </term>
   <def>
    <p>biomaterial engineering strategies aiming to boost the efficacy or reduce side effects of vaccines through co-delivering adjuvants, targeting immune cells, or protecting vaccines activities</p>
   </def>
  </def-item>
  <def-item>
   <term>
    <bold>vaccine delivery devices</bold>
   </term>
   <def>
    <p>tools for administering the vaccine formulations, and they can be used by medical workers or the patients themselves</p>
   </def>
  </def-item>
  <def-item>
   <term>
    <bold>pattern recognition receptors (PRRs)</bold>
   </term>
   <def>
    <p>proteins that can recognize pathogenic molecules as part of innate immunity in response to virus infection, including identifying pathogen-associated molecular patterns from a virus</p>
   </def>
  </def-item>
  <def-item>
   <term>
    <bold>adjuvants</bold>
   </term>
   <def>
    <p>supplementary agents that could be co-delivered with vaccines to boost the immune response, minimize the dosage of antigens, and maintain longer immunity</p>
   </def>
  </def-item>
  <def-item>
   <term>
    <bold>lymph nodes</bold>
   </term>
   <def>
    <p>round or bean-shaped clusters of cells containing abundant immune cells that can initiate the robust immune response toward viral infections</p>
   </def>
  </def-item>
 </def-list>
</glossary>
